43 related articles for article (PubMed ID: 3969319)
1. Radioimmunoassay for type I procollagen in growth hormone-deficient children before and during treatment with growth hormone.
Carey DE; Goldberg B; Ratzan SK; Rubin KR; Rowe DW
Pediatr Res; 1985 Jan; 19(1):8-11. PubMed ID: 3969319
[TBL] [Abstract][Full Text] [Related]
2. Long-term monitoring of treatment with recombinant human growth hormone by serial determinations of type III procollagen-related antigens in serum.
Danne T; Grüters A; Schnabel K; Burger W; L'Allemand D; Enders I; Helge H; Weber B
Pediatr Res; 1988 Feb; 23(2):167-71. PubMed ID: 3353159
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders.
Trivedi P; Risteli J; Risteli L; Hindmarsh PC; Brook CG; Mowat AP
Pediatr Res; 1991 Sep; 30(3):276-80. PubMed ID: 1945568
[TBL] [Abstract][Full Text] [Related]
4. Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature.
Gascoin-Lachambre G; Trivin C; Brauner R; Souberbielle JC
Growth Horm IGF Res; 2007 Jun; 17(3):194-200. PubMed ID: 17321775
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen in children with growth retardation.
Cinaz P; Hasanoglu E; Gökçora N; Dogukan S; Demir A
Mater Med Pol; 1994; 26(2):55-8. PubMed ID: 7745984
[TBL] [Abstract][Full Text] [Related]
7. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
Marini JC; Hopkins E; Glorieux FH; Chrousos GP; Reynolds JC; Gundberg CM; Reing CM
J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
[TBL] [Abstract][Full Text] [Related]
8. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone treatment for short stature.
Van Vliet G; Styne DM; Kaplan SL; Grumbach MM
N Engl J Med; 1983 Oct; 309(17):1016-22. PubMed ID: 6684729
[TBL] [Abstract][Full Text] [Related]
10. Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen.
Trivedi P; Hindmarsh P; Risteli J; Risteli L; Mowat AP; Brook CG
J Pediatr; 1989 Feb; 114(2):225-30. PubMed ID: 2915282
[TBL] [Abstract][Full Text] [Related]
11. Effect of growth hormone on serum lipoproteins in growth hormone deficiency.
Gács G; Romics L
Exp Clin Endocrinol; 1987 Sep; 90(2):227-31. PubMed ID: 3428364
[TBL] [Abstract][Full Text] [Related]
12. Serum leptin and IGF-I during growth hormone treatment in chronic renal failure.
Patel L; Webb NJ; Bradbury MG; Zaman N; Smith P; Lewis MA; Postlethwaite RJ; Price DA; Clayton PE
Pediatr Nephrol; 2002 Aug; 17(8):643-7. PubMed ID: 12185474
[TBL] [Abstract][Full Text] [Related]
13. Human growth hormone treatment in prepubertal children with achondroplasia.
Weber G; Prinster C; Meneghel M; Russo F; Mora S; Puzzovio M; Del Maschio M; Chiumello G
Am J Med Genet; 1996 Feb; 61(4):396-400. PubMed ID: 8834055
[TBL] [Abstract][Full Text] [Related]
14. Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation.
Plotnick LP; Van Meter QL; Kowarski AA
Pediatrics; 1983 Mar; 71(3):324-7. PubMed ID: 6681897
[TBL] [Abstract][Full Text] [Related]
15. Serum procollagen-III as indicator of therapeutic effect in children treated for somatotropin deficiency.
Lindstedt G; Weijkum L; Lundberg PA; Albertsson-Wikland K
Clin Chem; 1984 Nov; 30(11):1879-80. PubMed ID: 6488537
[No Abstract] [Full Text] [Related]
16. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
Amato G; Izzo G; La Montagna G; Bellastella A
Clin Endocrinol (Oxf); 1996 Jul; 45(1):27-32. PubMed ID: 8796135
[TBL] [Abstract][Full Text] [Related]
17. Somatomedin levels in the diagnosis and therapy of growth hormone deficiency.
Giannella-Neto D; Wajchenberg BL; Mendonca BB; Liberman B; Nery M; Macchione M; Spencer EM
Horm Metab Res; 1988 Mar; 20(3):175-81. PubMed ID: 3384400
[TBL] [Abstract][Full Text] [Related]
18. Serum bone GLA-protein in growth hormone deficient children.
Delmas PD; Chatelain P; Malaval L; Bonne G
J Bone Miner Res; 1986 Aug; 1(4):333-8. PubMed ID: 3509741
[TBL] [Abstract][Full Text] [Related]
19. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial with somatonorm in idiopathic growth hormone deficiency in children.
Shi YF; Liu R; Bao XL; Deng JY; Gunnarsson R
Chin Med J (Engl); 1990 Jun; 103(6):470-7. PubMed ID: 2119959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
